Skip to content

Solomon Mollik Azouz, M.D.

NPI 1366838864ActiveIndividual· Surgery, Plastic and Reconstructive Surgery· Dallas, TX

Surgery, Plastic and Reconstructive Surgery (M.D.) in Dallas, Texas, licensed in TX and AZ, with an NPI issued in April 2015. Part D covered 24 prescriptions written in 2024, 92% of them generic. Smith+nephew, Inc. was the largest of 14 companies reporting payments in 2025, $5,288 in all, mostly travel and lodging.

Overview

NPI1366838864
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedApr 10, 2015
Last updated in NPPESJan 2, 2019

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Plastic and Reconstructive Surgery (AZ)

Part D prescriptions in 2024

Prescriptions (claims)24 · 24 30-day fills
Total drug cost$107.79
Generic share92% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$5,288 · 39 payments from 14 companies
  • 2024$612.34 · 19 payments from 9 companies

Top paying companies in 2025

CompanyAmountPayments
Smith+nephew, Inc.$1,8519
Tela Bio, Inc.$1,7355
Abbvie Inc.$875.001
Ethicon US, LLC$326.716
Kerecis Limited$139.392

What the 2025 payments were for

  • Travel and Lodging$3,087 · 5 payments
  • Food and Beverage$1,326 · 33 payments
  • Consulting Fee$875.00 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Surgery, Plastic and Reconstructive Surgery providers in Dallas

All Surgery, Plastic and Reconstructive Surgery providers in Texas →